Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis
1 other identifier
observational
100
1 country
1
Brief Summary
The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2024
CompletedFirst Posted
Study publicly available on registry
October 23, 2024
CompletedStudy Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedDecember 12, 2024
December 1, 2024
2 months
October 22, 2024
December 9, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Presence of Stress Urinary Incontinence:
Stress urinary incontinence (SUI) is the involuntary leakage of urine during physical activities that increase abdominal pressure, such as coughing, sneezing, or lifting. In this study, the presence of SUI will be determined through a questionnaire that asks participants about symptoms and frequency of urine leakage during such activities.
0 day
Incontinence Quality of Life Scale (I-QOL):
The I-QOL is a validated questionnaire that measures the impact of urinary incontinence on a patient's quality of life. It assesses how incontinence affects daily activities, social interactions, and emotional well-being. Higher scores indicate better quality of life, while lower scores suggest that incontinence has a more significant negative impact on the patient's day-to-day functioning.
0 day
Skeletal Muscle Mass:
Measured by bioelectrical impedance analysis (BIA), this assesses the amount of muscle tissue in the body. Low skeletal muscle mass indicates sarcopenia.
0 day
Handgrip Strength
This is a simple test to measure muscle strength. Reduced handgrip strength is a sign of sarcopenia.
0 day
Study Arms (2)
Postmenopausal osteoporosis
Postmenopausal osteoporosis is diagnosed using Dual-X-ray Absorptiometry (DXA), which measures bone mineral density (BMD) and provides a T-score. A T-score of -2.5 or lower confirms the diagnosis of osteoporosis.
Postmenopausal non-osteoporotic women
These women maintain normal bone mineral density (BMD) levels, typically assessed using Dual-X-ray Absorptiometry (DXA). A T-score above -1.0 is considered normal.
Interventions
No intervention
Eligibility Criteria
Postmenopausal women
You may qualify if:
- Postmenopausal women with DXA measurements performed within the last 6 months.
- Based on DXA measurements:
- Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic).
- Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group.
- Aged 50-75 years
You may not qualify if:
- Refusal to participate in the study.
- History of neurological diseases, infections, surgeries, or trauma that could cause urinary incontinence or muscle loss.
- Presence of psychiatric disorders.
- Cognitive impairments.
- Use of medications that could affect the study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beylikdüzü State Hospital
Istanbul, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
October 22, 2024
First Posted
October 23, 2024
Study Start
November 15, 2024
Primary Completion
January 15, 2025
Study Completion
January 15, 2025
Last Updated
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share